Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
8
×
boston blog main
clinical trials
boston top stories
fda
medical device
national top stories
san francisco blog main
san francisco top stories
boston
cancer diagnostics
deals
raleigh-durham blog main
biotech ipos
cancer
freenome
grail
johnson & johnson
liquid biopsy
national
new york blog main
novartis
raleigh-durham top stories
rare disease drugs
san diego blog main
san francisco
thrive earlier detection
10x genomics
480 biomedical
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
alirocumab
ally bridge group
alnylam pharmaceuticals
amgen
aprea therapeutics
What
company
8
×
developing
ipo
tests
drug
medicines
million
new
raised
biotech
blood
brings
cancer
cash
deal
fda
genetic
plans
public
raises
therapeutics
treatment
acquire
adding
agreed
aims
analysis
announced
area
based
bay
billion
bio
biopsy
bring
broader
buildout
cholesterol
clearance
close
Language
unset
8
×
Current search:
unset
×
company
×
" national blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow